Your session is about to expire
← Back to Search
HIV with NAFLD for Fatty Liver Disease (Theratech Trial)
N/A
Waitlist Available
Led By Giada Sebastiani
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥18 years old at screening;
Able to provide informed consent, in French or English;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Theratech Trial Summary
To determine the distribution of visceral fat in people living with HIV (PLHIV) with NAFLD by clinical anthropometric indicators (wais-to-hip ratio), lipid accumulation product (waist circumference and triglycerides) and radiological techniques such as dual-energy X-ray absorptiometry (DXA) (trunk fat mass and fat mass through dual-energy X-ray absorptiometry).
Eligible Conditions
- Fatty Liver Disease
- HIV (Human Immunodeficiency Virus)
- Non-alcoholic Fatty Liver Disease
Theratech Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTheratech Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Determination of visceral fat
Theratech Trial Design
2Treatment groups
Active Control
Group I: HIV with NAFLDActive Control3 Interventions
HIV Nonalcoholic fatty liver disease patients
Group II: HIV without NAFLDActive Control3 Interventions
HIV without Nonalcoholic fatty liver disease patients
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
438 Previous Clinical Trials
159,018 Total Patients Enrolled
Giada SebastianiPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
2 Previous Clinical Trials
67 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger